Skip to main content

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More


Texas Medical Center

Cancer and Hematology
Phone: 832-824-4661
Fax: 832-825-7374


6621 Fannin Street, Suite 1630.14
Houston, TX 77030

Robert A. Krance, MD

Professor, Department of Pediatrics, Section of Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine


School Education Degree Year
St. Jude Children's Research Hospital Fellowship Hematology-Oncology 1977
St. Jude Children's Research Hospital Residency Pediatrics 1975
Rocky Mountain College Residency Pediatrics 1972
Rush University Medical Center Residency Pediatrics 1972
Rocky Mountain College Internship Pediatrics 1971
Rush University Medical Center Internship Pediatrics 1971
Loyola University of Chicago Medical School Doctor of Medicine 1970


Dr. Robert Krance is the Director of the Pediatric Bone Marrow Transplant (BMT)/Stem Cell Transplant Program at Texas Children’s Hospital. The clinical program, one of the most active in the country, treats patients with various hematologic, oncologic, immunologic and genetic disorders.

Dr. Krance coordinates the clinical activities of the cell and gene therapy and the pediatric bone marrow transplant programs. 

His clinical interests include bone marrow transplantation and cell and gene therapy.

Board Certifications
American Board of Pediatrics - Pediatric Medicine
American Board of Pediatrics - Hematology/Oncology


Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society for Transplantation and Cellular Therapy (ASTCT) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Hematology (ASH) Member

Research Statement

Dr. Robert Krance's research interests include: 1) the development of transplantation using alternative donors, 2) transplantation using less than fully HLA matched related donors, and 3) the impact of viral infection post-transplantation.

Current initiatives focus on the development of transplantation using alternative donors and less than fully HLA matched related donors. Investigations are under way into the use of antibodies directed against hematopoietic cells and methods of stem cell purification. In collaboration with other investigators in the Center for Cell and Gene Therapy (CAGT), new cell-based approaches are being conducted hopefully to diminish the impact of viral infection post transplantation.



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.